EditorialEditorial

Optimizing the cancer research landscape for the benefit of patients and society: A strategic perspective of the German Cancer Research Center (DKFZ) and its partnerships with university medical centers

Michael Baumann
Cancer Biology & Medicine November 2022, 19 (11) 1517-1522; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0586

References

  1. 1.↵
    Robert Koch-Institut: Cancer in Germany 2017/2018, Berlin 2021.
  2. 2.↵
    2. Wengler A,
    3. Rommel A,
    4. Plaß D,
    5. Gruhl H,
    6. Leddin J,
    7. Ziese T, et al.
    Years of life lost to death—a comprehensive analysis of mortality in Germany conducted as part of the BURDEN 2020 Project. Dtsch Arztebl Int. 2021; 118: 137–44.
    OpenUrl
  3. 3.↵
    Cancer Tomorrow (iarc.fr) https://gco.iarc.fr/tomorrow/en.
  4. 4.↵
    2. Arndt V,
    3. Dahm S,
    4. Kraywinkel K.
    Krebsprävalenz in Deutschland 2017. Onkologe. 2021; 27: 717–23.
    OpenUrl
  5. 5.↵
    Strategic Evaluation for the 4th Period of Program-oriented Funding (2021-2027), published by Helmholtz-Assocation/Research Field Health 2019.
  6. 6.↵
    2. Wild CP,
    3. Espina C,
    4. Bauld L,
    5. Bonanni B,
    6. Brenner H,
    7. Brown K, et al.
    Cancer prevention Europe. Mol Oncol. 2019; 13: 528–34.
    OpenUrl
  7. 7.↵
    GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022; 400: 563–91.
    OpenUrl
  8. 8.↵
  9. 9.↵
    NCT Strategic Concept, DKFZ Heidelberg 2022.
  10. 10.↵
    DKTK Evaluation Report, DKFZ Heidelberg 2021.
  11. 11.↵
    2. Sartor O,
    3. de Bono J,
    4. Chi KN,
    5. Fizazi K,
    6. Herrmann K,
    7. Rahbar K, et al.
    Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med. 2021; 385: 1091–103.
    OpenUrlCrossRefPubMed
  12. 12.↵
    WHO Classification of Tumours Editorial Board. WHO classification of tumors of the central nervous system, IARC 2016, 2021.
  13. 13.↵
    2. Pfister SM,
    3. Reyes-Múgica M,
    4. Chan JKC,
    5. Henrik Hasle H,
    6. Lazar AJ,
    7. Rossi S, et al.
    A summary of the inaugural WHO classification of pediatric tumors: transitioning from the optical into the molecular era. Cancer Discov. 2022; 12: 331–55
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section